Understanding Mechanisms and Outcomes of Trained Immunity (R01 Clinical Trial Not Allowed)
ID: 352012Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/352012

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-24-112.html
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted Jan 25, 2024 12:00 AM
  4. 4
    Due Jan 7, 2027 12:00 AM
Description

The National Institutes of Health is offering a grant opportunity titled "Understanding Mechanisms and Outcomes of Trained Immunity (R01 Clinical Trial Not Allowed)". This grant aims to support research that improves understanding of basic mechanisms and biomarkers of trained immunity, as well as the functional implications of trained immunity in various areas such as immune system development and function, immunity to vaccines or natural infections, and allergic diseases, autoimmunity, or rejection of organ/tissue/cell transplantation. The grant does not require cost sharing or matching requirements and falls under the category of Health. The eligible applicants include various institutions and organizations such as Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and U.S. Territories or Possessions. The grant has a closing date of January 7, 2027, and more information can be found at the following link: Understanding Mechanisms and Outcomes of Trained Immunity Grant. For any inquiries, contact NIH Grants Information at grantsinfo@nih.gov.

Point(s) of Contact
grantsinfo@nih.gov
Files
Title
Posted
PAR-24-112-Full-Announcement.html
4/10/2024
Similar Opportunities
Understanding Mechanisms and Outcomes of Trained Immunity (R21 Clinical Trial Not Allowed)
Active
National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "Understanding Mechanisms and Outcomes of Trained Immunity (R21 Clinical Trial Not Allowed)". This grant aims to support research that improves understanding of basic mechanisms and biomarkers of trained immunity, as well as the functional implications of trained immunity. The research should focus on immune system development and function, immunity to vaccines or natural infections, or allergic diseases, autoimmunity, or rejection of organ/tissue/cell transplantation. The grant does not require cost sharing or matching. The maximum award ceiling is $275,000. Other eligible applicants include Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions, Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities, Indian/Native American Tribal Governments, Non-domestic (non-U.S.) Entities, Regional Organizations, Tribally Controlled Colleges and Universities, and U.S. Territories or Possessions. The closing date for applications is January 7, 2027. For more information and to apply, visit the following link: [Understanding Mechanisms and Outcomes of Trained Immunity Grant](http://grants.nih.gov/grants/guide/pa-files/PAR-24-111.html). For any inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
Human Leukocyte Antigen (HLA) and Killer-cell Immunoglobulin-like Receptor (KIR) Region Genomics in Immune-Mediated Diseases (U01 Clinical Trial Not Allowed)
Active
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "Human Leukocyte Antigen (HLA) and Killer-cell Immunoglobulin-like Receptor (KIR) Region Genomics in Immune-Mediated Diseases (U01 Clinical Trial Not Allowed)". This grant aims to support research in three main areas: 1) defining associations between variations in HLA and KIR genetic regions and immune-mediated diseases, 2) elucidating mechanisms underlying these associations to advance therapeutic opportunities, and 3) validating association data to improve the predictive power of clinical disease screening. The grant is a Cooperative Agreement and falls under the category of Health. The funding opportunity does not require cost sharing or matching. The maximum award ceiling is $400,000. The grant is open to various eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. Territory or Possession. However, non-domestic (non-U.S.) Entities (Foreign Organizations) and non-domestic components of U.S. Organizations are not eligible to apply. The grant opportunity will close on August 20, 2024, and the archive date is set for September 25, 2024. For more information and to apply, interested parties can visit the following website: [http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-24-017.html](http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-24-017.html). If there are any inquiries, they can be directed to NIH Grants Information at grantsinfo@nih.gov.
Mechanisms of Inducing HIV Immunity in Early Life (MIEL) (U01 Clinical Trial Not Allowed)
Active
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "Mechanisms of Inducing HIV Immunity in Early Life (MIEL) (U01 Clinical Trial Not Allowed)". This grant aims to support basic and applied research to understand the mechanisms for establishing, developing, and maintaining immunity to HIV in early life, specifically from birth to less than 12 years of age. The research will focus on the impact of prophylactic vaccination and broadly neutralizing HIV antibodies (bNAbs) in protecting against the acquisition of HIV infection. The funding instrument type for this opportunity is a Cooperative Agreement, and there is no cost sharing or matching requirement. The grant falls under the category of Health and is classified as discretionary. The opportunity is open to various eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities (TCCUs), and U.S. Territory or Possession. The closing date for applications is October 9, 2024. The maximum award ceiling for this grant is $750,000. For more information and to apply, interested parties can visit the following website: [http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-24-029.html](http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-24-029.html). For any inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
Active
National Institutes of Health
The National Institutes of Health (NIH) is offering a funding opportunity titled "NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)". This opportunity falls under the category of Health and is a Discretionary grant. The funding instrument type is a Cooperative Agreement. The grant does not require cost sharing or matching. The purpose of this funding opportunity is to support the implementation of investigator-initiated, high-risk clinical trials and mechanistic studies associated with high-risk clinical trials. Mechanistic work in clinical trials is important as it promotes the understanding of human diseases and the development of future therapeutic modalities. Eligible applicants for this grant include Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities (TCCUs), and U.S. Territories or Possessions. The close date for this grant opportunity is January 13, 2027, and the archive date is February 18, 2027. For more information and to apply, interested parties can visit the following website: [http://grants.nih.gov/grants/guide/pa-files/PAR-24-100.html](http://grants.nih.gov/grants/guide/pa-files/PAR-24-100.html). For any inquiries or additional information, please contact NIH Grants Information at grantsinfo@nih.gov.
NIAID Research Education Program (R25 Clinical Trial Not Allowed)
Active
National Institutes of Health
The National Institutes of Health (NIH) is offering a grant opportunity titled "NIAID Research Education Program (R25 Clinical Trial Not Allowed)". This grant falls under the category of Health and is a discretionary funding opportunity. The grant does not require cost sharing or matching. The purpose of this grant is to support research education activities in the mission areas of the NIH, specifically the National Institute of Allergy and Infectious Diseases (NIAID). The goal of the program is to enhance the training of a diverse workforce to meet the nation's biomedical, behavioral, and clinical research needs in the NIAID mission areas. The grant is open to various eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. Territory or Possession. Non-domestic (non-U.S.) Entities (Foreign Institutions) and non-U.S. components of U.S. Organizations are not eligible to apply. However, foreign components, as defined in the NIH Grants Policy Statement, are allowed. The grant opportunity has a closing date of October 9, 2024, and the last updated date was March 15, 2022. The grant description and additional information can be found at the following URL: [http://grants.nih.gov/grants/guide/pa-files/PAR-22-134.html](http://grants.nih.gov/grants/guide/pa-files/PAR-22-134.html). For any inquiries, please refer to Section VII. Agency Contacts within the full opportunity announcement or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.